In this regard, GC has been shown to express simple O-glycan antigens [19], and recently an association between the expression of the glycan antigen Thomsen-Friedenreich (TF) and the MSI status of GC tumors has been described, highlighting this glycan antigen as a biomarker with potential consequences for patient stratification [40]. The gene discussed is TF; the disease is gastric cancer.